CD3 discovers new small molecule drugs in order to bridge the gap between innovative biomedical research emerging from academic institutions or SMEs and the pharmaceutical industry.

Researchers at the University of Leuven are joining forces with Janssen Pharmaceuticals and the Wellcome Trust to discover and develop candidate antiviral drugs for the prevention and treatment of dengue infection.


Success stories